The current valuation score of 111 Inc is 9.73, ranking 8 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -39.32, which is -99.71% below the recent high of -0.11 and -60.14% above the recent low of -62.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.